While the steatosis reduction in the liver that we observed would be considered beneficial, it was also important to confirm that no detrimental levels of steatosis occurred in the heart, as it had been reported that whole-body inhibition of lipolysis in ATGL KO mice led to severe cardiac steatosis [26]. This evidence concerns the gene PNPLA2 and steatosis.